Innovation in Oral Care Awards

Innovation in Oral Care Awards is sponsored by International Association for Dental, Oral, and Craniofacial Research (IADR) and Haleon. This program funds cross-disciplinary research developing new oral care technologies with broad public health impact, supporting innovative compounds, biomaterials, or devices for routine consumer use. Projects should have a clear pathway to broad consumer access.

IADR Innovation in Oral Care Awards The Innovation in Oral Care Awards (“Award(s)”) are jointly sponsored by IADR and Haleon, with funding provided exclusively by Haleon. The IADR mission is to drive dental, oral and craniofacial research for health and well-being worldwide.

It does so through its Divisions and Sections as well as in partnership with international dental associations, industry, health agencies, and scientific and educational professional organizations. These innovation awards offer opportunities for investigators to conduct dental research that will have a direct impact on the oral health of the public.

As a leader in consumer oral care, Haleon recognizes the need for pioneers to produce innovative technologies that can be used routinely by the public to maintain and improve oral health and quality of life. The Award(s) is intended to help investigators pursue innovative and novel research in oral care, above and beyond the bounds of traditional dental research.

Three competitive Award(s), of up to $50,000 each, will be provided to recipients to advance oral care programs directed toward the development of innovative and novel compounds, biomaterials or devices that can be used ultimately at the public health level.

Examples of areas of interest could include, but not be limited to: inhibition or removal of biofilms etc. adhering to natural or artificial surfaces, modification of those surfaces to inhibit biofilms and other deposits, stains and odors, adhesives for removable prosthetic devices, inhibition of tooth surface loss and gingival recession, and amelioration of their effects, and counteracting the oral effects of dry mouth, systemic illness, hormonal disturbances or physiological aging.

The Award(s) will be provided in the form of an unrestricted research grant which carries no obligation to the recipient’s organization for licensure, patenting, or transfer confidential information, although Haleon may discuss the possibility of future collaboration with some applicants.

Criteria Required for submitted proposals: For the purposes of this Award Program, oral care is defined as: products, devices or delivery systems used frequently by consumers to maintain or improve their oral health status and quality of life, and/or devices fabricated by the assistance of dental professionals and placed in the oral cavity, and which require frequent or daily maintenance by the consumer.

Any proposed innovation or new technology should provide significant benefits to the consumer, such as improved oral health and/or quality of life. Ultimately the proposed innovations or technologies should be available to large numbers of people through retail channels such as ‘over-the-counter’ (OTC) or general sale.

Initially, however, it may be appropriate for availability to be on a prescription basis for a limited period before transitioning to OTC. Restorative materials, dental instruments and equipment, and diagnostics for non-oral conditions should not receive much consideration unless the technological advance provides significant benefit to the oral health and quality of life status of the public.

The principal investigator listed in the application must be a current member of, or at the time of submission have made bona fide application to, IADR. To fulfill the quest for innovation, proposals should be collaboratively sponsored by at least one researcher whose principal expertise is in an area of biotechnology other than a dental science.

The intent is to encourage collaboration with researchers from outside the dental institution; nevertheless, the most important criterion involves the innovative nature of the proposed research. Applicants should possess advanced degrees and must hold an affiliation with an academic center, not-for-profit institution, or for-profit entities such as biotechnology start-up companies.

Letters of support from the principal investigator’s (PI) institution are required and should describe the nature of the PI’s appointment and commitments to the PI, such as lab and office space, technical assistance or travel funds. The IADR Innovation in Oral Care Awards Committee will consider all proposals received by the deadline.

Criteria for review will include: Originality and novelty of the oral care, (as defined above), research proposal. Does the project employ novel concepts, approaches or methods? Are the aims original and innovative?

Are existing paradigms challenged or new methods or technologies developed? Potential importance to oral health and quality of life. Does the study address an important problem?

What effect might this project have on current methods and concepts that drive this field? Evidence of the applicants’ abilities to conduct the proposed research. Are the named investigators appropriately trained to carry out this work?

Is the work proposed appropriately matched to the experience levels of the researchers? Appropriateness of methodologies and scope. Does the scientific environment in which the work will be done contribute to the probability of success?

Does the project employ useful collaborative arrangements? Is there evidence of institutional support? Budgetary emphasis should be on additional technical assistance, equipment, etc. related specifically to pursuing the new idea or method rather than providing significant salary support for principal investigators.

The IADR and Review Panel members will treat all application materials submitted for consideration for funding in a confidential manner. The IADR and Review Panel members will not use application materials submitted by prospective awardees and evaluation materials for any purposes other than those related to the acceptance and evaluation of applications or the administration of awards.

Haleon is not privy to the review and judging process. Haleon shall not use, disclose, or transfer for any purpose other than the award program any information or intellectual property disclosed in the course or as part of the Award Program. Proposals are limited to: Research Plan, (6-page limit), Impact Statement - Brief Paragraph on why your research will have a direct impact on the oral health of the public.

Biographical Sketch, (5-page limit); and Budget (tables for the Budget are included in the online submission package and are not part of the 6-page limit). Tables and figures are included in the 6-page limit. No appendices (other than investigator resumes and letters of support) are allowed.

A title for the project and an abstract of no more than 350 words should also be provided by the applicant. Only online applications will be accepted. Space limitations will be defined by the online application program.

Research Plan (not to exceed 6 pages): The research plan should be divided into: State concisely the goals of the proposed research and summarize the expected outcome(s), including the impact that the results of the proposed research will exert on the research field(s) involved.

List succinctly the specific objectives of the research proposed, e.g., to test a stated hypothesis, create a novel design, solve a specific problem, challenge an existing paradigm or clinical practice, address a critical barrier to progress in the field, or develop new technology.

Include Significance, Innovation and Approach Explain the importance of the problem or critical barrier to progress in the field that the proposed project addresses. Explain how the proposed project will improve scientific knowledge, technical capability, and/or clinical practice in one or more broad fields.

Describe how the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field will be changed if the proposed aims are achieved. Explain how the application challenges and seeks to shift current research or clinical practice paradigms.

Describe any novel theoretical concepts, approaches or methodologies, instrumentation or intervention(s) to be developed or used, and any advantage over existing methodologies, instrumentation or intervention(s). Explain any refinements, improvements, or new applications of theoretical concepts, approaches or methodologies, instrumentation or interventions.

Describe the overall strategy, methodology, and analyses to be used to accomplish the specific aims of the project. Include how the data will be collected, analyzed, and interpreted as well as any resource sharing plans as appropriate. Discuss potential problems, alternative strategies, and benchmarks for success anticipated to achieve the aims.

If the project is in the early stages of development, describe any strategy to establish feasibility, and address the management of any high risk aspects of the proposed work. Point out any procedures, situations, or materials that may be hazardous to personnel and precautions to be exercised. 3.

Time Frame - Provide an estimated time for accomplishing key goals. If the proposed work is likely to take longer than two years, indicate the total time frame and overall scope of the project and what applicant hopes to accomplish. 4.

Literature Cited - Provide a short list (not more than 10 citations). 5. Resources - Specify what general laboratory/office facilities are at applicant’s disposal to conduct the research.

Indicate what specialized equipment and facilities are required. Consultant/Collaborative/Contractual Arrangements - If needed, include letters verifying any consulting, collaborative, or contractual arrangements necessary for the conduct of the research. Biographical Sketch (not to exceed 5 pages)(One for each investigator): The sketch should include the applicant's name and position title.

This should be followed by education/training information (earliest training and degree first), and Research and professional experiences (concluding with the current position). Complete references to all scientific/clinical publications during the past four years, as well as pertinent earlier publications should be included.

All biographical sketches should include the following: Education Degrees, Postgraduate Training, Postgraduate Qualifications, Awards, Current Position Positions Held, Voluntary Experience, Committee Assignments, Professional Memberships, Activities/Interests, Bibliography. A biographical sketch for each applicant should be submitted. Budget and Budget Justification: A completed budget is required for acceptance.

Please supply explanation and justification where necessary. Per IADR policy, reimbursed institutional overhead cannot exceed eight (8) percent of the award amount. You MUST download and utilize one of the pre-defined GSK's project budgets and save it on your computer.

For projects lasting 12 months or less, please complete the " One Year Budget Form ". For projects lasting between 12 and 24 months, please complete the " Two Year Budget Form ", which breaks down the budget by year. Projects longer than 2 years will not be considered.

Budgetary emphasis should be on additional technical assistance, equipment, etc. related specifically to pursuing the new idea or method rather than providing significant salary support for principal investigators.

Time Frame for Submission, Review, and Award: Award(s) Announcement and notification: Award Policies and Conditions: IADR shall be responsible for establishing and enforcing all rules and regulations concerning the grant of Award(s) and complying with all applicable laws, rules and regulations.

Successful applicants will be required to sign a Letter of Agreement and Acceptance concerning the conditions and policies under which the grant is awarded prior to receipt of the Award(s). Innovation in Oral Care grants are not renewable.

Any continuation of funding after the initial grant is contingent upon Haleon interest in a specific project and subsequent negotiation with the applicants beyond the Innovation in Oral Care grant per se. Financial Administration and Reports: The Award(s) will be made to the grantee institution and not to the individual.

The clinical investigator(s) is responsible for the scientific conduct of the research and the institution is responsible for financial and administrative matters. The institution is responsible for administration of the funds in accordance with acceptable policies and procedures for sponsored project accounting and in accordance with the terms and conditions of the Award(s). Projects must be completed within two years.

For those projects that require more than one year for completion, the principal investigator must provide an interim report. Payment will be made in two installments. The second payment is contingent upon receipt of the interim report where appropriate.

IADR and Haleon reserve the right to make no Award. Human Subjects, Radiation Safety and Environmental Health Issues: All research conducted as part of the IADR Innovation in Oral Care Awards involving human subjects shall follow all applicable laws, regulations, and guidelines and, if involving human subjects or otherwise appropriate, have the approval of the relevant Institutional Review Board (IRB).

Copies of the IRB approval must be submitted prior to funding of the Award(s). All presentations and publications (as well as posters and/or abstracts at scientific meetings) that result from the support provided by the Award(s) ward should acknowledge that support in writing.

The following citation is suggested: "Funding for this project [research title], has been provided through an Innovation in Oral Care Award, conducted by the International Association for Dental, Oral, and Craniofacial Research and sponsored by Haleon."

Applications and Further Information: Except for disclosures to IADR or Haleon as agreed to by applicant, all applicants shall agree not to disclose their application or the contents thereof to others until after the IADR General Session & Exhibition.

After the judging process has been completed, Haleon will have access to applicant names, their institutions, the proposal title and abstract only, and may wish to discuss potential commercialization of the concepts disclosed in the applications with the applicants, if the applicants so agree.

Interested parties are welcome to submit a brief proposal letter outlining the research to IADR and asking for a determination as to whether such research would qualify for consideration.

IADR Innovation in Oral Care Award Book Ambarish Ghosh, Indian Institute of Science Indian Institute of Science An Ultraprecise Nanorobotic Biomineralization Platform for Deep Dentinal Tubule Sealing and the Alleviation of Dental Hypersensitivity co-investigators: Peddi Shanmukh Srinivas, Mutlu Özcan, and Debayan Dasgupta University of North Carolina Oligosaccharide “Butter” Balm for at Home Periodontal Care co-investigators: Jian Liu and Kristy Ainslie National University of Singapore AI-Enabled Biomimetic Hydrogels for Biosafety Testing of Dental Materials Prasanna Neelakantan, University of Alberta and co-investigators: Santiago Orrego and Cesar de la Fuente Yong Wang, University of Missouri- Kansas City and co-investigators: Zhonghua Peng and Viviane Hass Ollie Yiru Yu, The University of Hong Kong and co-Investigators: Chun-Hung Chu, Christie Ying-Kei Lung, and Kelsey Xingyun Ge Geelsu Hwang (University of Pennsylvania, Philadelphia, USA) Rania Nassar (The University of Hong Kong, SAR, China) and co-investigator: Mohannad Nassar, Abiola Senok, and David Williams Silvana Papagerakis (Université Laval, Quebec City, Canada) and co-Investigators: Benoit Gosselin Kassapa Ellepola (University of Illinois at Chicago, USA) and co-investigator: Russell Pesavento Zhou Ye (The University of Hong Kong, SAR, China) and co-investigators: Conrado Aparicio and Yifan Lin Peter Zilm (University of Adelaide, Australia) and co-Investigators: Yanping He, Stuart Dashper, Krasimir Vasilev Yoav Finer (University of Toronto, ON, Canada) Joao Ferreira (Chulalongkorn University, Bangkok, Thailand ) and co-investigators Kai Soo Tan, Supansa Yodmuang, Waranyoo Phoolcharoen, and Catherine H.

L. Hong Livia Tenuta (University of Michigan, Ann Arbor, USA) and co-investigators Joerg Lahann and Brian Clarkson Cesar de la Fuente (University of Pennsylvania, Philadelphia, USA) and co-investigator Marcelo Torres. Nicole Ritzert (ADA Science and Research Institute, Bethesda, MD, USA) and co-investigators Anna Kalmykov and Erin Claussen.

Prasanna Neelakantan (University of Hong Kong, SAR, China) and co-investigators Conrado Aparicio, Lakshman Samaranayke, Julian Tanner, Gordon Rammer, Shanthini Kalimuthu. So Ran Kwon (Loma Linda University, California, USA) and co-investigators Roberto Savignano, Christopher Perry. Isabelle Denry (University of Iowa, Iowa City, USA) and co-investigator Amanda Haes.

Jonathan An (University of Washington, Seattle, USA) and co-investigator Matt Kaeberlein. Sahar Ansari (University of California, Los Angeles, USA) and co-investigator Tara Aghaloo. Shan Jiang (University of Hong Kong, SAR, China ) and co-investigators Chengfei Zhang, Edward Lo, Xuechen Li, and Linxian Li.

Marco Bottino (University of Michigan, Ann Arbor, USA) and co-investigators Steven Schwendeman and Hajime Sasaki. Luiz Eduardo Bertassoni (Oregon Health and Science University Portland, OR, USA) and co-investigator Gaurav Sahay. Prasanna Neelakantan (The University of Hong Kong, SAR, China) and co-investigators Celine Levesque, Frederic Cuisinier, PierreYves Collart Dutilleul, Chu Chun Hung, Lakshman Samanaranake and Nihal Bandara.

Rajesh V. Lalla (University of Connecticut, Farmington, CT, USA) and co-investigators Diane Burgess. Mikako Hayashi (Osaka University, Japan) and co-investigators Takayoshi Nakano and Reo Uemura.

Grayson Marshall (University of California, San Francisco, USA) and co-investigators Stefan Habelitz, Sally Marshall and Kuniko Saeki. Petros Papagerakis (University of Saskatchewan, Saskatoon, Canada) and co-investigators Nikos Chronis and Silvana Papagerakis. Catherine.

Ovitt (University of Rochester, NY, USA) and co-investigator Vyacheslan Korshunov. Nicholas. Jakubovics (Newcastle University, Newcastle Upon Tyne, England, UK) and co-investigators Michael Hall, Philip Preshaw and Grant Burgess.

Nihal Bandara (University of Queensland, Australia) and co-investigators Lakshman Samaranayake and Hugh David Charles Smyth. Lizeng Gao (University of Pennsylvania, Philadelphia, USA) and co-investigator David Cormode. Janet Moradian-Oldak, (University of Southern California, Los Angeles, USA).

Alireza Moshaverinia, (University of Southern California, Los Angeles, USA) and co-investigator Ali Khademhosseini, Homa Zadeh, and Songtao Shi. Jake Jinkun Chen (Tufts University, Medford, MA, USA) and co-investigators Qisheng Tu and Lily Dong. Yvonne Kapila (University of Michigan,Ann Arbor, USA) and co-investigators J.

Fenno, and Alexander Rickard. Keith L. Kirkwood (Medical University of South Carolina, Charleston, USA) and co-investigators Frank Alexis.

Bernhard Ganss (University of Toronto, Ontario, Canada) and co-investigator Eli Sone. Marlise Klein (University of Rochester, NY, USA) and co-investigators Danielle Benoit, Hyun Koo and Falsetta Wood. Dong Wang (University of Nebraska Medical Center, Omaha, USA) and co-investigator Richard Reinhardt.

Simone Duarte (New York University, NY, USA) and co-investigators Deepak Saxena and Nelson Silva. Christopher Irwin (Queen’s University, Belfast, Ireland) and co-investigators Fionnuala Lundy and Brian Walker. Doron Steinberg (Hebrew University, Jerusalem, Israel) and co-investigator Michael Friedman.

Scott De Rossi (Georgia Health Sciences University College of Dental Medicine, Augusta, USA) and co-investigators Douglas Dickinson, Stephen Hsu, Stephen Looney and Kalu Ogbureke. David T. Wong (University of California, Los Angeles, USA).

Hui Wu (University of Alabama at Birmingham, USA) and co-investigators Suzanne Michalek and Christian Melander. Robert Patrick Allaker (Queen Mary & Westfield College, University of London, UK) and co-investigators Jie Huang and Guogang Ren. Craig Miller (University of Kentucky College of Dentistry, Lexington, USA) and co-investigator Jeffrey L .

Ebersole. Daniel Grenier (Groupe de Recherche en Ecologie Buccale, Université Laval, Quebec, Canada) and co-investigator Francesco Epifano. Sandra Bordin (University of Washington, Seattle, USA) and co-investigator Xingde Li.

Eric Reynolds (Melbourne Dental School,The University of Melbourne,Australia) and co-investigator Stuart Dashper. Rena D’Souza (Baylor College of Dentistry,Texas A&M Health Science Center, USA) and co-investigators Jeffrey Hartgerink and Gottfried Schmalz. Urban Hägg and co-investigators (The Prince Philip Dental Hospital, University of Hong Kong).

Keith Kirkwood (Medical University of South Carolina, USA). David T. W.

Wong (University of California, Los Angeles, USA). Toshihisa Kawai (The Forsyth Institute, Boston, Massachusetts, USA). Fionnuala T .

Lundy (Queen’s University, Belfast, UK) and David Orr (University of Ulster at Coleraine, Coleraine, UK). Gordon Ramage (Glasgow University Dental School & Hospital, Scotland, UK) Yen-Tung Andy Teng (University of Rochester, NY, USA). Cun-Yu Wang and Lijian Jin (University of Michigan, Ann Arbor, USA and University of Hong Kong, SAR, China).

Hyun (Michel) Koo and co-investigators (University of Rochester, NY, USA) John Featherstone and co-investigators (UCSF, USA). Peter Holbrook and co-investigators (University of Iceland). Lin Tao (University of Illinois-Chicago, USA).

Marie-Claude Amoureux and co-investigators (Clarigen, Inc., Carlsbad, CA, USA). Jack Ferracane and co-investigators (Oregon Health & Science University, Portland, USA). Spencer Redding and co-investigators (UTHSC, San Antonio, USA).

Doron Steinberg and co-investigators (Hebrew University, Jerusalem, Israel). Questions about the award? Assistant Manager, Awards, Fellowships, & Grants We respect your right to privacy.